Catalyst Wire Dossier Catalyst Wire Dossier

ABACAVIR AND LAMIVUDINE

abacavir/lamivudine · Lupin Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for ABACAVIR AND LAMIVUDINE, covering 2015-12-22 to 2025-04-16. Get the full timeline:

Most recent: FDA Approved: ABACAVIR AND LAMIVUDINE — Original Application (Camber Pharmaceuticals, Inc.)

See pricing